Gebel T, Arand M, Oesch F
Institute of Toxicology, University of Mainz, Germany.
FEBS Lett. 1992 Aug 31;309(1):37-40. doi: 10.1016/0014-5793(92)80734-x.
The process of peroxisome proliferation in rodent liver by hypolipidemic compounds and related substances has recently been shown to be receptor-mediated. In the present study, we have examined the effect of oral administration of the strong peroxisome proliferator fenofibrate on the hepatic expression level of the peroxisome proliferator activated receptor (PPAR) in rats. Immunoblots of rat liver cytosols and nuclear extracts using antibodies raised against recombinant PPAR/beta-galactosidase fusion proteins revealed a pronounced increase in the amount of PPAR protein in response to fenofibrate treatment. This induction could also be confirmed at the level of RNA by Northern blotting. A time-course investigation showed a delayed accumulation of mRNA in response to the treatment, starting on day 2 after a latency period of at least one day. Thus, induction of the PPAR as a response to peroxisome proliferators represents one important dimension of the pleiotropic effects of peroxisome proliferators.
最近研究表明,降血脂化合物及相关物质在啮齿动物肝脏中引发的过氧化物酶体增殖过程是由受体介导的。在本研究中,我们检测了口服强效过氧化物酶体增殖剂非诺贝特对大鼠肝脏中过氧化物酶体增殖物激活受体(PPAR)表达水平的影响。使用针对重组PPAR/β-半乳糖苷酶融合蛋白制备的抗体对大鼠肝脏胞质溶胶和核提取物进行免疫印迹分析,结果显示,非诺贝特处理后PPAR蛋白量显著增加。通过Northern印迹法在RNA水平也证实了这种诱导作用。一项时间进程研究表明,在至少一天的潜伏期后,从第2天开始,mRNA响应处理出现延迟积累。因此,作为对过氧化物酶体增殖剂的反应,PPAR的诱导代表了过氧化物酶体增殖剂多效性作用的一个重要方面。